Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the study alliance leukemiaCarsten Müller‐Tidow, Matthias Stelljes, Steffen Koschmieder et al.|Leukemia|2015Cited by 49
Immune signatures of prodromal multiple sclerosis in monozygotic twinsLisa Ann Gerdes, Luisa Klotz, Claudia Janoschka et al.|Proceedings of the National Academy of Sciences|2020Cited by 42
DNMT3A mutations in exon 23 are associated with improved survival in AML patients treated with Azacytidine plus standard chemotherapyPetra Tschanter, Carsten Müller‐Tidow, Utz Krug et al.|Kölner Universitäts PublikationsServer (Universität zu Köln)|2015Cited by 0